Page 98 - 2025中醫藥與天然藥物聯合學術研討會-中醫藥與天然藥物的挑戰X機遇與未來大會手冊
P. 98

Plant-derived Exosome-like Nanovesicles: Novel Therapeutics from Nature


                                                               2
                            1
                                            2
                                                                                ,2
               Hyo In Kim,  Hye-Lin Kim,  Leo E. Otterbein,  Jinbong Park*

               1  Department of Surgery, Beth  Israel Deaconess  Medical Center, Harvard Medical School,
                 Boston, MA 02215, United States
               2  Department of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul
                 02447, Republic of Korea
               * E-mail: thejinbong@khu.ac.kr

               Abstract
                  Plant-derived  exosome-like  nanovesicles  have  emerged  as  a  promising  class  of  natural

               therapeutics due to their low immunogenicity, high absorption efficiency, and capacity to carry
               diverse bioactive cargos such as RNAs, proteins, lipids, and metabolites. This presentation will
               highlight the therapeutic potential of these plant-derived nanovesicles, with a particular focus
               on  their  application  in  metabolic  diseases.  Here,  we  investigate  exosome-like  nanovesicles

               derived from the medicinal plant Platycodon grandiflorus (P-ELNs) as a potential anti-obesity
               therapy. P-ELNs, when administered in vitro to 3T3-L1 adipocytes, activated AMP-activated
               protein kinase (AMPK), leading to suppressed adipogenesis, enhanced lipolysis, and improved
               glucose homeostasis. This correlated in vivo in a murine model of high-fat diet (HFD)-fed mice

               where P-ELN treatment reduced body weight gain and white adipose tissue (WAT) mass as
               compared to control. Moreover, P-ELN treatment promoted glycolytic beige fat formation and
               induced  non-shivering  thermogenesis.  P-ELNs  showed  a  favorable  safety  profile  with  no
               systemic, hepatic, or renal toxicity observed. Collectively, these findings support P-ELNs as a

               safe and effective therapeutic strategy to reduce body weight in part by promoting AMPK-
               dependent remodeling of inguinal WAT into glycolytic beige fat. The novelty and impact of our
               findings lie in both the identification of P-ELNs as a safe, plant-based nanotherapeutic, and in
               the conceptual advance that glycolytic beige fat can be pharmacologically regulated. We view

               this as a paradigm shift in obesity treatment strategies, positioning glycolytic beige fat as a
               viable therapeutic target by P-ELNs.

               Keywords: Platycodon grandiflorus; Plant-derived exosome-like nanovesicles; Obesity;
               AMP-activated protein kinase; Glycolytic beige fat
















                                                           76
   93   94   95   96   97   98   99   100   101   102   103